These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24819155)

  • 1. Reduction of maternal circulating endothelial progenitor cells in human pregnancies with intrauterine growth restriction.
    Calcaterra F; Taddeo A; Colombo E; Cappelletti M; Martinelli A; Calabrese S; Mavilio D; Cetin I; Della Bella S
    Placenta; 2014 Jul; 35(7):431-6. PubMed ID: 24819155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Endothelial Progenitor Cells: A Possible Biomarker for Idiopathic Fetal Growth Restriction in Human Pregnancies.
    Singh A; Jaiswar SP; Priyadarshini A; Deo S
    J Mother Child; 2023 Jun; 27(1):182-189. PubMed ID: 37991978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction].
    Semczuk-Sikora A; Krzyzanowski A; Stachowicz N; Robak J; Kraczkowski J; Kwiatek M; Semczuk M
    Ginekol Pol; 2007 Oct; 78(10):783-6. PubMed ID: 18200969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
    Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
    Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?
    Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
    Am J Obstet Gynecol; 2012 Feb; 206(2):163.e1-7. PubMed ID: 22055338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental gene expression patterns of epidermal growth factor in intrauterine growth restriction.
    Rab A; Szentpéteri I; Kornya L; Börzsönyi B; Demendi C; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):96-9. PubMed ID: 23810060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced circulating retinol and non-esterified fatty acids in pregnancies complicated with intrauterine growth restriction.
    Ortega-Senovilla H; Alvino G; Taricco E; Cetin I; Herrera E
    Clin Sci (Lond); 2009 Nov; 118(5):351-8. PubMed ID: 19656084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of stromal cell-derived factor-1 (CXCL12) and circulating endothelial progenitor cells in women with idiopathic heavy menstrual bleeding.
    Elsheikh E; Andersson E; Sylvén C; Ericzon BG; Palmblad J; Mints M
    Hum Reprod; 2014 Jan; 29(1):49-56. PubMed ID: 24218400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of activation of peripheral blood dendritic cells in human pregnancies complicated by intrauterine growth restriction.
    Cappelletti M; Giannelli S; Martinelli A; Cetin I; Colombo E; Calcaterra F; Mavilio D; Della Bella S
    Placenta; 2013 Jan; 34(1):35-41. PubMed ID: 23182380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.
    Malamitsi-Puchner A; Boutsikou T; Economou E; Sarandakou A; Makrakis E; Hassiakos D; Creatsas G
    Mediators Inflamm; 2005 Oct; 2005(5):293-7. PubMed ID: 16258196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
    Cowans NJ; Spencer K; Meiri H
    Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.
    Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S
    Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction.
    Sattar N; Greer IA; Galloway PJ; Packard CJ; Shepherd J; Kelly T; Mathers A
    J Clin Endocrinol Metab; 1999 Jan; 84(1):128-30. PubMed ID: 9920072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine growth restriction-induced deleterious adaptations in endothelial progenitor cells: possible mechanism to impair endothelial function.
    Oliveira V; de Souza LV; Fernandes T; Junior SDS; de Carvalho MHC; Akamine EH; Michelini LC; de Oliveira EM; Franco MDC
    J Dev Orig Health Dis; 2017 Dec; 8(6):665-673. PubMed ID: 28689502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
    Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
    Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.